• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=29492214).
  
• Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=29492214).
  

PubMed=16638848; DOI=10.1158/1078-0432.CCR-05-1940
Stefania Scala, Paola Giuliano, Paolo Antonio Ascierto, Caterina Ierano, Renato Franco, Maria Napolitano, Alessandro Ottaiano, Maria Luisa Lombardi, Monica Luongo, Ester Simeone, Daniele Castiglia ...Show all 19 authors... , Francesca Mauro, Ileana De Michele, Rosa Calemma, Gerardo Botti, Corrado Caraco, Gianfranco Nicoletti, Rocco Alfredo Satriano, Giuseppe Castello; Show fewer authors
Human melanoma metastases express functional CXCR4.
Clin. Cancer Res. 12:2427-2433(2006)

PubMed=21424129; DOI=10.3892/or.2011.1220
Antonella Manca, Maria Cristina Sini, Francesco Izzo, Paolo Antonio Ascierto, Fabiana Tatangelo, Gerardo Botti, Giusy Gentilcore, Marilena Capone, Nicola Mozzillo, Carla Rozzo, Antonio Cossu ...Show all 13 authors... , Francesco Tanda, Giuseppe Palmieri; Show fewer authors
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.
Oncol. Rep. 25:1495-1502(2011)

PubMed=21863025; DOI=10.1038/bjc.2011.324; PMCID=PMC3185940
Antonella De Luca, Luana Lamura, Luigi Strizzi, Cristin Roma, Antonio D'Antonio, Naira V. Margaryan, Giuseppe Pirozzi, Mei-Yu Hsu, Gerardo Botti, Ettore Mari, Mary J.C. Hendrix ...Show all 13 authors... , David S. Salomon, Nicola Normanno; Show fewer authors
Expression and functional role of CRIPTO-1 in cutaneous melanoma.
Br. J. Cancer 105:1030-1038(2011)

PubMed=29492214; DOI=10.18632/oncotarget.23989; PMCID=PMC5823576
Maria Cristina Sini, Valentina Doneddu, Panagiotis Paliogiannis, Milena Casula, Maria Colombino, Antonella Manca, Gerardo Botti, Paolo Antonio Ascierto, Amelia Lissia, Antonio Cossu, Giuseppe Palmieri;
Genetic alterations in main candidate genes during melanoma progression.
Oncotarget 9:8531-8541(2018)